TTNP Stock - Titan Pharmaceuticals, Inc.
Unlock GoAI Insights for TTNP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | $1,000 | $60,000 | $1.53M | $4.84M |
| Gross Profit | $-5,000 | $1,000 | $-136,000 | $1.33M | $4.37M |
| Gross Margin | N/A | 100.0% | -226.7% | 87.0% | 90.2% |
| Operating Income | $-4,557,000 | $-7,277,000 | $-10,235,000 | $-9,354,000 | $-7,351,000 |
| Net Income | $-4,706,000 | $-5,569,000 | $-10,177,000 | $-8,114,000 | $-20,728,000 |
| Net Margin | N/A | -556900.0% | -16961.7% | -531.7% | -428.4% |
| EPS | $-5.23 | $-7.41 | $-15.15 | $-4.06 | $-10.38 |
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
Visit WebsiteEarnings History & Surprises
TTNPEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Sep 30, 2025 | — | $-0.57 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.65 | — | — |
Q2 2025 | May 14, 2025 | — | $-0.62 | — | — |
Q1 2025 | Mar 20, 2025 | — | $-0.85 | — | — |
Q1 2025 | Jan 3, 2025 | — | $-0.83 | — | — |
Q3 2024 | Aug 15, 2024 | — | $-2.29 | — | — |
Q2 2024 | May 15, 2024 | — | $-1.24 | — | — |
Q2 2024 | Apr 1, 2024 | — | $-2.52 | — | — |
Q4 2023 | Nov 14, 2023 | — | $-0.40 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.11 | — | — |
Q2 2023 | May 15, 2023 | — | $-2.20 | — | — |
Q1 2023 | Mar 31, 2023 | $-4.40 | $-3.61 | +18.0% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-4.20 | $-3.60 | +14.3% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-5.20 | $-3.60 | +30.8% | ✓ BEAT |
Q2 2022 | May 16, 2022 | — | $-4.80 | — | — |
Q1 2022 | Mar 25, 2022 | $-7.00 | $-5.20 | +25.7% | ✓ BEAT |
Q4 2021 | Nov 15, 2021 | $-0.35 | $-3.80 | -985.7% | ✗ MISS |
Q3 2021 | Aug 16, 2021 | $-0.35 | $-4.80 | -1271.4% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.85 | $-5.60 | -558.8% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $-1.33 | $-0.86 | +35.3% | ✓ BEAT |
Latest News
Frequently Asked Questions about TTNP
What is TTNP's current stock price?
What is the analyst price target for TTNP?
What sector is Titan Pharmaceuticals, Inc. in?
What is TTNP's market cap?
Does TTNP pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TTNP for comparison